Modeling the cost of influenza: The impact of missing costs of unreported complications and sick leave

BMC Public Health

Volumn 10, Issue , 2010, Pages

  Xue, Yiting ^a,b   Kristiansen, Ivar Sønbø ^a   De Blasio, Birgitte Freiesleben ^a,b  

^a UNIVERSITY OF OSLO   (Norway)

^b NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ALGORITHM; ARTICLE; COST; ECONOMICS; HUMAN; INFLUENZA; MEDICAL LEAVE; METHODOLOGY; MONTE CARLO METHOD; NORWAY; POISSON DISTRIBUTION; STATISTICAL MODEL;

ALGORITHMS; COSTS AND COST ANALYSIS; HUMANS; INFLUENZA, HUMAN; MODELS, ECONOMETRIC; MONTE CARLO METHOD; NORWAY; POISSON DISTRIBUTION; SICK LEAVE;

EID: 78549241649     PISSN: None     EISSN: 14712458     Source Type: Journal    
DOI: 10.1186/1471-2458-10-724     Document Type: Article

References (21)

1. Revised estimates of influenza-associated excess mortality, United States, 1995 through 2005. IM Foppa MM Hossain, Emerg Themes Epidemiol 2008 5 26 10.1186/1742-7622-5-26 19116016
2. Excess Mortality Associated with Influenza in England and Wales. RE Clifford JWG Smith HE Tillett PJ Wherry, International Journal of Epidemiology 1977 6 115 128 10.1093/ije/6.2.115 892976
3. Mortality associated with influenza and respiratory syncytial virus in the United States. WW Thompson DK Shay E Weintraub L Brammer N Cox LJ Anderson,, et al. JAMA 2003 289 179 186 10.1001/jama.289.2.179 12517228 (Pubitemid 36068705)
4. Influenza-associated hospitalization in a subtropical city. CM Wong L Yang KP Chan GM Leung KH Chan Y Guan,, et al. Plos Medicine 2006 3 485 492 10.1371/journal.pmed.0030121
5. The impact of influenza and influenza-like illness on productivity and healthcare resource utilization in a working population. M Keech AJ Scott PJJ Ryan, Occupational Medicine-Oxford 1998 48 85 90 10.1093/occmed/48.2.85 (Pubitemid 28077598)
6. The Impact of Influenza on Working Days Lost A Review of the Literature. M Keech P Beardsworth, Pharmacoeconomics 2008 26 911 924 10.2165/00019053- 200826110-00004 18850761
7. Heterogeneous case definitions used for the surveillance of influenza in Europe. JF Aguilera WJ Paget A Mosnier ML Heijnen H Uphoff J van der Velden,, et al. European Journal of Epidemiology 2003 18 751 754 10.1023/A:1025337616327 12974549
8. Synchrony of Clinical and Laboratory Surveillance for Influenza in Hong Kong. L Yang CM Wong EH Lau KP Chan CQ Ou JS Peiris, Plos One 2008 3
9. Innsatsstyrt finansiering 2008. http://www.helsedirektoratet.no/ finansieringsordninger/publikasjoner/regelverk-innsatsstyrt-finansiering-2008- 90924?dummy=null
10. Norwegian Prescription Database. http://www.reseptregisteret.no/
11. Exchange rate. http://www.xe.com/ict/
12. Convalescence and sick leave after influenza. C Pedersen, Ugeskr Laeger 2009 171 2913 2915 19814941
13. Arbeidsgiveravgift. http://www.skatteetaten.no/Templates/ TabellerOgSatser.aspx?id = 77525&epslanguage=NO
14. Feriepenger. http://www.arbeidstilsynet.no/fakta.html?tid=78190
15. Pensjonsinnskudd. http://www.sfso.no/templates/Word-799.aspx
16. The burden of influenza in children. M Iskander R Booy S Lambert, Current Opinion in Infectious Diseases 2007 20 259 263 10.1097/QCO.0b013e3280ad4687 17471035
17. StatFlu. http://www.s-gem.se/statflu
18. Estimating influenza-related excess mortality and reproduction numbers for seasonal influenza in Norway, 1975-2004. JM Gran B Iversen O Hungnes OO Aalen, Epidemiol Infect 2010 1 10
19. The economic impact of pandemic influenza in the United States: priorities for intervention. MI Meltzer NJ Cox K Fukuda, Emerg Infect Dis 1999 5 659 671 10.3201/eid0505.990507 10511522
20. The annual impact of seasonal influenza in the US: Measuring disease burden and costs. NAM Molinari IR Ortega-Sanchez ML Messonnier WW Thompson PM Wortley E Weintraub,, et al. Vaccine 2007 25 5086 5096 10.1016/j.vaccine.2007. 03.046 17544181
21. Emerging infections: pandemic influenza. WP Glezen, Epidemiol Rev 1996 18 64 76 8877331